<p><strong>表格 8.5 (EPT/RI)</strong></p>
<p><strong>豁免主要交易者與認可中介身份的公開交易披露，服務於客户的能力</strong></p>
<p><strong>收購守則第 8.5 條（“守則”）</strong></p>
<p><strong>1. 關鍵信息</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>(a) 豁免主要交易者名稱：</strong></td>
<td>Investec Bank plc</td>
</tr>
<tr>
<td><strong>(b) 本表格所涉及的要約方/被要約方的相關證券名稱：</strong> <em>每個要約方/被要約方使用單獨的表格</em></td>
<td>Advanced Medical Solutions Group Plc</td>
</tr>
<tr>
<td><strong>(c) 與豁免主要交易者相關的要約方名稱：</strong></td>
<td>Investec 是 Advanced Medical Solutions Group plc 的顧問和聯合經紀人</td>
</tr>
<tr>
<td><strong>(d) 交易日期：</strong></td>
<td>2026 年 4 月 30 日</td>
</tr>
<tr>
<td><strong>(e) 除上述 1(b) 中的公司外，豁免主要交易者是否在披露任何其他要約方的相關信息？</strong> <em>如果是現金要約或可能的現金要約，請註明 “無”</em></td>
<td><em>無</em></td>
</tr>
</tbody>
</table>
<p><strong>2. 豁免主要交易者的交易</strong></p>
<p><em>如果在 1(b) 中提到的要約方或被要約方的相關證券中有多個類別的交易，請為每個額外的相關證券類別複製表格 2(a)、(b)、(c) 或 (d)（視情況而定）。</em></p>
<p><em>所有價格和其他貨幣金額的貨幣單位應予以説明。</em></p>
<p><strong>(a) 購買和銷售</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>普通股</td>
</tr>
<tr>
<td><strong>購買/銷售</strong></td>
<td>銷售</td>
</tr>
<tr>
<td><strong>證券總數</strong></td>
<td>13,080</td>
</tr>
<tr>
<td><strong>每單位支付/收到的最高價格</strong></td>
<td>245.5</td>
</tr>
<tr>
<td><strong>每單位支付/收到的最低價格</strong></td>
<td>245.5</td>
</tr>
</tbody>
</table>
<p><strong>(b) 現金結算衍生交易</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>產品描述</strong> <em>例如 CFD</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>交易性質</strong> <em>例如 開立/平倉多頭/空頭頭寸，增加/減少多頭/空頭頭寸</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>參考證券數量</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位價格</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
<p><strong>(c) 股票結算衍生交易（包括期權）</strong></p>
<p><strong>(i) 寫入、出售、購買或變更</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>產品描述</strong> <em>例如 看漲期權</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>寫入、購買、出售、變更等</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>與期權相關的證券數量</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位行使價格</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>類型</strong> <em>例如 美式、歐式等</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>到期日</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位支付/收到的期權金</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
<p><strong>(ii) 行使</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>產品描述</strong> <em>例如 看漲期權</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>行使/被行使</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>證券數量</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位行使價格</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
<p><strong>(d) 其他交易（包括認購新證券）</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>交易性質</strong> <em>例如 認購、轉換</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>詳情</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位價格（如適用）</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
<p><strong>3. 其他信息</strong></p>
<p><strong>(a) 賠償和其他交易安排</strong></p>
<ul>
<li><strong>有關豁免主要交易者與任何要約方或與要約方協同行動的任何人的相關證券的賠償或期權安排，或任何協議或理解（正式或非正式）的詳情，這可能是促使交易或避免交易的誘因：</strong> <em>不可撤銷的承諾和意向書不應包括。如果沒有此類協議、安排或理解，請註明 “無”</em></li>
<li>無</li>
</ul>
<p><strong>(b) 與期權或衍生品相關的協議、安排或理解</strong></p>
<ul>
<li><strong>有關豁免主要交易者與任何其他人之間的任何協議、安排或理解（正式或非正式）的詳情，涉及：</strong> <strong>(i) 任何相關證券在任何期權下的投票權；或</strong> <strong>(ii) 任何衍生品所參考的相關證券的投票權或未來的收購或處置：</strong> <em>如果沒有此類協議、安排或理解，請註明 “無”</em></li>
<li>無</li>
</ul>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>披露日期：</strong></td>
<td><strong>2026 年 5 月 1 日</strong></td>
</tr>
<tr>
<td><strong>聯繫人姓名：</strong></td>
<td><strong>Priyali Bhattacharjee</strong></td>
</tr>
<tr>
<td><strong>聯繫電話：</strong></td>
<td><strong>+91-9923757332</strong></td>
</tr>
</tbody>
</table>
<p><em>根據守則第 8 條的公開披露必須向監管信息服務進行。</em></p>
<p><em>面板的市場監測單位可就守則的交易披露要求進行諮詢，電話 +44 (0) 20 7638 0129。</em></p>
<p><em>守則可在面板網站上查看，網址為 sssssssw</em> <em>www.thetakeoverpanel.org.uk</em> <em>.</em></p>

<p>Investec Bank plc（作為豁免主要交易商）關於在 Advanced Medical Solutions Group plc 的交易的 Form 8.5（EPT/RI）披露。2026 年 4 月 30 日，Investec 以每單位 245.5 的價格出售了 13,080 股普通股。沒有報告其他交易或協議。該披露由 Priyali Bhattacharjee 於 2026 年 5 月 1 日發佈，並提供了進一步諮詢收購守則的聯繫方式</p>

<p><strong>FORM 8.5 (EPT/RI)</strong></p>
<div class="lb-trans"><p><strong>表格 8.5 (EPT/RI)</strong></p>
</div><p><strong>PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY</strong></p>
<div class="lb-trans"><p><strong>豁免主要交易者與認可中介身份的公開交易披露，服務於客户的能力</strong></p>
</div><p><strong>Rule 8.5 of the Takeover Code (the “Code”)</strong></p>
<div class="lb-trans"><p><strong>收購守則第 8.5 條（“守則”）</strong></p>
</div><p><strong>1. KEY INFORMATION</strong></p>
<div class="lb-trans"><p><strong>1. 關鍵信息</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>(a) Name of exempt principal trader:</strong></td>
<td>Investec Bank plc</td>
</tr>
<tr>
<td><strong>(b) Name of offeror/offeree in relation to whose relevant securities this form relates:</strong> <em>Use a separate form for each offeror/offeree</em></td>
<td>Advanced Medical Solutions Group Plc</td>
</tr>
<tr>
<td><strong>(c) Name of the party to the offer with which exempt principal trader is connected:</strong></td>
<td>Investec is Advisor &amp; Joint Broker to Advanced Medical Solutions Group plc</td>
</tr>
<tr>
<td><strong>(d) Date dealing undertaken:</strong></td>
<td>30th April 2026</td>
</tr>
<tr>
<td><strong>(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?</strong> <em>If it is a cash offer or possible cash offer, state “N/A”</em></td>
<td><em>N/A</em></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>(a) 豁免主要交易者名稱：</strong></td>
<td>Investec Bank plc</td>
</tr>
<tr>
<td><strong>(b) 本表格所涉及的要約方/被要約方的相關證券名稱：</strong> <em>每個要約方/被要約方使用單獨的表格</em></td>
<td>Advanced Medical Solutions Group Plc</td>
</tr>
<tr>
<td><strong>(c) 與豁免主要交易者相關的要約方名稱：</strong></td>
<td>Investec 是 Advanced Medical Solutions Group plc 的顧問和聯合經紀人</td>
</tr>
<tr>
<td><strong>(d) 交易日期：</strong></td>
<td>2026 年 4 月 30 日</td>
</tr>
<tr>
<td><strong>(e) 除上述 1(b) 中的公司外，豁免主要交易者是否在披露任何其他要約方的相關信息？</strong> <em>如果是現金要約或可能的現金要約，請註明 “無”</em></td>
<td><em>無</em></td>
</tr>
</tbody>
</table>
</div><p><strong>2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER</strong></p>
<div class="lb-trans"><p><strong>2. 豁免主要交易者的交易</strong></p>
</div><p><em>Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.</em></p>
<div class="lb-trans"><p><em>如果在 1(b) 中提到的要約方或被要約方的相關證券中有多個類別的交易，請為每個額外的相關證券類別複製表格 2(a)、(b)、(c) 或 (d)（視情況而定）。</em></p>
</div><p><em>The currency of all prices and other monetary amounts should be stated.</em></p>
<div class="lb-trans"><p><em>所有價格和其他貨幣金額的貨幣單位應予以説明。</em></p>
</div><p><strong>(a) Purchases and sales</strong></p>
<div class="lb-trans"><p><strong>(a) 購買和銷售</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>Ordinary shares</td>
</tr>
<tr>
<td><strong>Purchases/ sales</strong></td>
<td>Sales</td>
</tr>
<tr>
<td><strong>Total number of securities</strong></td>
<td>13,080</td>
</tr>
<tr>
<td><strong>Highest price per unit paid/received</strong></td>
<td>245.5</td>
</tr>
<tr>
<td><strong>Lowest price per unit paid/received</strong></td>
<td>245.5</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>普通股</td>
</tr>
<tr>
<td><strong>購買/銷售</strong></td>
<td>銷售</td>
</tr>
<tr>
<td><strong>證券總數</strong></td>
<td>13,080</td>
</tr>
<tr>
<td><strong>每單位支付/收到的最高價格</strong></td>
<td>245.5</td>
</tr>
<tr>
<td><strong>每單位支付/收到的最低價格</strong></td>
<td>245.5</td>
</tr>
</tbody>
</table>
</div><p><strong>(b) Cash-settled derivative transactions</strong></p>
<div class="lb-trans"><p><strong>(b) 現金結算衍生交易</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Product description</strong> <em>e.g. CFD</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Nature of dealing</strong> <em>e.g. opening/closing a long/short position, increasing/reducing a long/short position</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Number of reference securities</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Price per unit</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>產品描述</strong> <em>例如 CFD</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>交易性質</strong> <em>例如 開立/平倉多頭/空頭頭寸，增加/減少多頭/空頭頭寸</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>參考證券數量</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位價格</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
</div><p><strong>(c) Stock-settled derivative transactions (including options)</strong></p>
<div class="lb-trans"><p><strong>(c) 股票結算衍生交易（包括期權）</strong></p>
</div><p><strong>(i) Writing, selling, purchasing or varying</strong></p>
<div class="lb-trans"><p><strong>(i) 寫入、出售、購買或變更</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Product description</strong> <em>e.g. call option</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Writing, purchasing, selling, varying etc.</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Number of securities to which option relates</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Exercise price per unit</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Type</strong> <em>e.g. American, European etc.</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Expiry date</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Option money paid/ received per unit</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>產品描述</strong> <em>例如 看漲期權</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>寫入、購買、出售、變更等</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>與期權相關的證券數量</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位行使價格</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>類型</strong> <em>例如 美式、歐式等</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>到期日</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位支付/收到的期權金</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
</div><p><strong>(ii) Exercise</strong></p>
<div class="lb-trans"><p><strong>(ii) 行使</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Product description</strong> <em>e.g. call option</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Exercising/ exercised against</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Number of securities</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Exercise price per unit</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>產品描述</strong> <em>例如 看漲期權</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>行使/被行使</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>證券數量</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位行使價格</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
</div><p><strong>(d) Other dealings (including subscribing for new securities)</strong></p>
<div class="lb-trans"><p><strong>(d) 其他交易（包括認購新證券）</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Class of relevant security</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Nature of dealing</strong> <em>e.g. subscription, conversion</em></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Details</strong></td>
<td>N/A</td>
</tr>
<tr>
<td><strong>Price per unit (if applicable)</strong></td>
<td>N/A</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>相關證券類別</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>交易性質</strong> <em>例如 認購、轉換</em></td>
<td>無</td>
</tr>
<tr>
<td><strong>詳情</strong></td>
<td>無</td>
</tr>
<tr>
<td><strong>每單位價格（如適用）</strong></td>
<td>無</td>
</tr>
</tbody>
</table>
</div><p><strong>3. OTHER INFORMATION</strong></p>
<div class="lb-trans"><p><strong>3. 其他信息</strong></p>
</div><p><strong>(a) Indemnity and other dealing arrangements</strong></p>
<div class="lb-trans"><p><strong>(a) 賠償和其他交易安排</strong></p>
</div><ul>
<li><strong>Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:</strong> <em>Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”</em></li>
<li>None</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>有關豁免主要交易者與任何要約方或與要約方協同行動的任何人的相關證券的賠償或期權安排，或任何協議或理解（正式或非正式）的詳情，這可能是促使交易或避免交易的誘因：</strong> <em>不可撤銷的承諾和意向書不應包括。如果沒有此類協議、安排或理解，請註明 “無”</em></li>
<li>無</li>
</ul>
</div><p><strong>(b) Agreements, arrangements or understandings relating to options or derivatives</strong></p>
<div class="lb-trans"><p><strong>(b) 與期權或衍生品相關的協議、安排或理解</strong></p>
</div><ul>
<li><strong>Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:</strong> <strong>(i) the voting rights of any relevant securities under any option; or</strong> <strong>(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:</strong> <em>If there are no such agreements, arrangements or understandings, state “none”</em></li>
<li>None</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>有關豁免主要交易者與任何其他人之間的任何協議、安排或理解（正式或非正式）的詳情，涉及：</strong> <strong>(i) 任何相關證券在任何期權下的投票權；或</strong> <strong>(ii) 任何衍生品所參考的相關證券的投票權或未來的收購或處置：</strong> <em>如果沒有此類協議、安排或理解，請註明 “無”</em></li>
<li>無</li>
</ul>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Date of disclosure:</strong></td>
<td><strong>01 May 2026</strong></td>
</tr>
<tr>
<td><strong>Contact name:</strong></td>
<td><strong>Priyali Bhattacharjee</strong></td>
</tr>
<tr>
<td><strong>Telephone number:</strong></td>
<td><strong>+91-9923757332</strong></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>披露日期：</strong></td>
<td><strong>2026 年 5 月 1 日</strong></td>
</tr>
<tr>
<td><strong>聯繫人姓名：</strong></td>
<td><strong>Priyali Bhattacharjee</strong></td>
</tr>
<tr>
<td><strong>聯繫電話：</strong></td>
<td><strong>+91-9923757332</strong></td>
</tr>
</tbody>
</table>
</div><p><em>Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.</em></p>
<div class="lb-trans"><p><em>根據守則第 8 條的公開披露必須向監管信息服務進行。</em></p>
</div><p><em>The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0) 20 7638 0129.</em></p>
<div class="lb-trans"><p><em>面板的市場監測單位可就守則的交易披露要求進行諮詢，電話 +44 (0) 20 7638 0129。</em></p>
</div><p><em>The Code can be viewed on the Panel’s website at sssssssw</em> <em>www.thetakeoverpanel.org.uk</em> <em>.</em></p>
<div class="lb-trans"><p><em>守則可在面板網站上查看，網址為 sssssssw</em> <em>www.thetakeoverpanel.org.uk</em> <em>.</em></p>
</div>

表格 8.5（EPT/RI）- Advanced Medical Solutions Group plc